Work

Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy

Year: 2017

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.740.740

Authors: Jesus G. Berdeja, Yi Lin, Noopur Raje, Nikhil Munshi, David Siegel, Michaela Liedtke, Sundar Jagannath, Marcela V. Maus, Ashley Turka, Lyh Ping Lam, Kristen Hege, Richard A. Morgan, Michael Travis Quigley, James N. Kochenderfer

Institutions: Sarah Cannon, Tennessee Oncology, Mayo Clinic, Massachusetts General Hospital, Harvard University, Dana-Farber Cancer Institute, Hackensack University Medical Center, Stanford Medicine, Stanford University, Mount Sinai Hospital, Bluebird Bio (United States), National Cancer Institute, National Institutes of Health Clinical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2778897040

Cites:

Cited by: 85

Related to: 10